Prostacyclin (PGI2) is released by vascular endothelial cells and serves as a potent vasodilator, inhibitor of platelet aggregation, and moderator of vascular smooth muscle cell proliferation–migration–differentiation. The function of prostacyclin is mediated via a seven transmembrane GPCR, IP1, which is known to couple to Gs and Gq signaling pathways. Mice lacking the IP1 receptor have shown increased susceptibility to thrombosis, enhanced injury-induced vascular proliferation and platelet activation, as well as reperfusion injury. The recent world-wide withdrawal of selective COX-2 inhibitors, rofecoxib(Vioxx) and valdecoxib(Bextra) is also due to their discriminating suppression of COX-2-derived prostacyclin and IP1-mediated cardioprotective effects, leading to increased risk of cardiovascular events.
Product Information | |
---|---|
Catalog #: | ACC-RG0745 |
Gene Name | PTGIR |
Abbr | HEK293-HuPTGIR/Clytin |
Alias | PTGIR,IP,PRIPR,MGC102830 |
Growth Properties | Adherent |
Host Cell | HEK293 |
Morphology | Epithelial |
Shipping | Dry ice |
Product Type | GPCR Expressing Cell |
Species | Human |
Product Format | frozen |
searchKeyword | PTGIR,IP,PRIPR,MGC102830 |
Related Products
Catalog | Product Name | Gene Name | Species | Morphology | Price |
---|---|---|---|---|---|
ACC-RG1589 | Human PTGIR/beta-Arrestin Stable Cell Line-HEK293 | PTGIR | Human | Epithelial | INQUIRY |
ACC-RG1590 | Human PTGIR/beta-Arrestin Stable Cell Line-CHO | PTGIR | Human | Epithelial-like | INQUIRY |
ACC-RG1702 | Human PTGIR Stable Cell Line-CHO-K1/Gα15 | PTGIR | Human | INQUIRY | |
ACC-RG0368 | Human PTGIR-FLAG Stable Cell Line-CHO | PTGIR | Human | Epithelial-like | INQUIRY |
ACC-RG0476 | Human PTGIR/Gs Stable Cell Line-CHO | PTGIR | Human | Epithelial-like | INQUIRY |
ACC-RG0744 | Human PTGIR/Galpha15 Stable Cell Line-Chem-1 | PTGIR | Human | INQUIRY |
Inquiry